1. Home
  2. IBEX vs CLLS Comparison

IBEX vs CLLS Comparison

Compare IBEX & CLLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo IBEX Limited

IBEX

IBEX Limited

HOLD

Current Price

$28.80

Market Cap

383.7M

Sector

Technology

ML Signal

HOLD

Logo Cellectis S.A.

CLLS

Cellectis S.A.

HOLD

Current Price

$4.12

Market Cap

384.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
IBEX
CLLS
Founded
2017
1999
Country
United States
France
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
383.7M
384.3M
IPO Year
2017
2014

Fundamental Metrics

Financial Performance
Metric
IBEX
CLLS
Price
$28.80
$4.12
Analyst Decision
Hold
Strong Buy
Analyst Count
2
3
Target Price
$35.00
$8.33
AVG Volume (30 Days)
110.8K
33.9K
Earning Date
05-07-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
28.26
N/A
EPS
1.65
N/A
Revenue
$558,273,000.00
N/A
Revenue This Year
$14.13
N/A
Revenue Next Year
$5.68
$0.62
P/E Ratio
$17.40
N/A
Revenue Growth
9.77
N/A
52 Week Low
$23.40
$1.33
52 Week High
$42.99
$5.48

Technical Indicators

Market Signals
Indicator
IBEX
CLLS
Relative Strength Index (RSI) 52.42 59.57
Support Level $28.26 $3.25
Resistance Level $30.27 $4.48
Average True Range (ATR) 0.86 0.21
MACD 0.29 0.09
Stochastic Oscillator 61.41 68.36

Price Performance

Historical Comparison
IBEX
CLLS

About IBEX IBEX Limited

IBEX Ltd delivers innovative business process outsourcing (BPO), smart digital marketing, online acquisition technology, and end-to-end customer engagement solutions to help companies acquire, engage, and retain valuable customers. It is an end-to-end provider of technology-enabled customer lifecycle experience (CLX) solutions to optimize customer acquisition, engagement, expansion, and experience for its clients. IBEX operates through the Business process outsourcing segment. Its services cover three areas: Digital and omni-channel Customer Experience (ibex Connect), Digital Marketing and E-Commerce (ibex Digital) and Digital CX surveys and analytics (ibex CX). It caters to a broad range of industries, such as telecommunications, cable, financial services, and healthcare.

About CLLS Cellectis S.A.

Cellectis SA is a clinical stage biotechnological company, employing the core proprietary technologies to develop products based on gene-editing, with a portfolio of allogeneic Chimeric Antigen Receptor T-cells, or UCART, product candidates in the field of immuno-oncology and gene-edited hematopoietic stem and progenitor cells, or HSPC product candidates in other therapeutic indications.

Share on Social Networks: